Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 10,170
+80 (0.79%)
At close: Sep 3, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 146.64 billion as of September 4, 2026. Its market cap has decreased by -32.84% in one year.
Market Cap
146.64B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
10,170.00
ChartMarket Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 146.64B, an increase of 38.07%. That is a compound annual growth rate of 4.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 146.64B | -16.49% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 211.97B |
| Kanaph Therapeutics | 209.88B |
| NIBEC | 182.45B |
| Genome & Company | 182.00B |
| Bio Solution | 160.76B |
| ISU Abxis | 145.57B |
| Prestige Biologics | 135.99B |
| Y-Biologics | 132.46B |